相关实验视频

Updated: Jun 26, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

铁素修饰的半三明治化 (III) 和 (II) 复合物和抗癌应用

Changjian Ji¹, Ruixiao Dong¹, Pei Zhang²

¹Key Laboratory of Life-Organic Analysis of Shandong Province, Institute of Anticancer Agents Development and Theranostic Application, School of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, Shandong, China.

Journal of inorganic biochemistry

|May 10, 2024

概括

新的铁修饰的和复合物显示出作为非抗癌药物的前景. 基于的复合物,特别是Ir3,对具有低细胞毒性的A549癌细胞表现出显著的抗增殖和抗迁移作用.

科学领域:

有机金属化学有机金属化学
癌症治疗治疗癌症治疗
药品化学药品化学是一个

背景情况:

基于的药物是标准化疗剂,但具有局限性.
有机金属复合物提供了替代治疗策略.
铁素,和复合物被探索为潜在的白金替代品.

研究的目的:

为了合成和评估铁素修饰的半三明治 (II) 和 (III) 基化复合物.
为了评估它们在A549癌细胞中的体外抗癌潜力.
为了比较它们与思普拉丁的疗效,并研究它们的作用机制.

主要方法:

合成了六种新的铁改性 (II) 和 (III) 复合物.
针对A549肺癌细胞的体外抗增殖试验.
细胞毒性和抗迁移测定.
线粒体积累,细胞循环,反应性氧物种 (ROS) 生成,以及对最活跃复合物的亡研究 (Ir3).

主要成果:

所有合成的复合物都表现出对A549细胞的体外抗增殖活性.
基于的复合物显示出优越的活性和协同作用的抗癌效应.
这些复合物表现出低细胞毒性和有效的抗迁移特性.
复杂的Ir3积聚在线粒体中,诱导S相细胞循环停止,增加ROS水平,并触发A549细胞的亡.

结论:

铁素改性 (III) 复合物是有前途的非抗癌剂.
复杂的Ir3表现出涉及线粒体功能障碍和亡诱导的多目标机制.
这项研究为开发新型多活性有机金属抗癌药物提供了结构性基础.

关键词:

这是一种抗癌药物.铁烯是一种铁烯.一半三明治结构的结构.(III) 复合物 (III) 复合物 (II) 复合物 (II) 复合物是一个复合物.

更多相关视频

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene

Published on: March 20, 2017

相关概念视频

Reduction of Alkenes: Asymmetric Catalytic Hydrogenation

Reduction of Alkenes: Asymmetric Catalytic Hydrogenation

Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration

Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration

The rate of acid-catalyzed hydration of alkenes depends on the alkene's structure, as the presence of alkyl substituents at the double bond can significantly influence the rate.